Trial Profile
A proof-of-concept study investigating diagnostic and therapeutic applications of PSMA-SR6 for the treatment of prostate cancer
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 15 Jan 2016
Price :
$35
*
At a glance
- Drugs PSMA SR6 (Primary)
- Indications Prostate cancer
- Focus Diagnostic use; Proof of concept; Therapeutic Use
- 15 Jan 2016 New trial record
- 11 Jan 2016 According to an Advanced Accelerator Applications media release, this trial is expected to start in 2016.